|
2001P-0156: ANDA Suitability for Ketamine Hydrochloride Injection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed Date
|
| Submitter Code
|
| Submitter
|
| FR Date
|
| FR Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 03/28/2001
|
| 03/29/2001
|
| International
|
| Bioniche Pharma
(Canada) Ltd.
|
|
|
|
|
|
|
| Letter
Bioniche Labeling
Reference-Labeling
|
| ACK 3/29/01
|
|
|
| Signature:
|
| Rhonda Noll
|
|
|
|
|
| ACK1
|
| 03/29/2001
|
| 03/29/2001
|
| Other
Organization
|
| HFA-305
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
|
|
| PAV1
|
| 08/21/2001
|
| 08/21/2001
|
| Other
Organization
|
| HFD-600 to Bioniche
Pharma (Canada) LTD
|
|
|
|
|
|
|
| pdf
|
| SEE CP1 CLOSED
|
|
|
| Signature:
|
| Gary J Buehler
|
|
|
|
|
| SUP1
|
| 08/24/2001
|
| 08/24/2001
|
| International
|
| Bioniche Pharma
(Canada) Ltd.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Rhonda Noll
|
|
|
|
|
|
Top | Up
Page last updated:
August 22, 2007
|
